Mesenchymal-like BCSCs with CD44+/CD24− characteristics are primarily quiescent and placed at the tumor-invasive front, while epithelial-like BCSCs express ALDH1, are proliferative, and are more centrally located. Here, ALDH1A1 is linked to neoplasm.